These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 23727030)

  • 21. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.
    Chang Y; Jung HS; Yun KE; Cho J; Cho YK; Ryu S
    Am J Gastroenterol; 2013 Dec; 108(12):1861-8. PubMed ID: 24100261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Yu F; Wang X; Zhao H; Hao Y; Wang W
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
    PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat.
    Quintás G; Caiment F; Rienda I; Pérez-Rojas J; Pareja E; Castell JV; Jover R
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
    Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Liu CH; Ampuero J; Gil-Gómez A; Montero-Vallejo R; Rojas Á; Muñoz-Hernández R; Gallego-Durán R; Romero-Gómez M
    J Hepatol; 2018 Dec; 69(6):1335-1348. PubMed ID: 30142428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
    Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
    Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    Erhartova D; Cahova M; Dankova H; Heczkova M; Mikova I; Sticova E; Spicak J; Seda O; Trunecka P
    PLoS One; 2019; 14(11):e0224820. PubMed ID: 31703079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population.
    He Z; Yang JJ; Zhang R; Li HT; Wu L; Jiang F; Jia WP; Hu C
    J Dig Dis; 2019 Apr; 20(4):189-195. PubMed ID: 30756471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma.
    Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
    BMC Gastroenterol; 2016 Dec; 16(1):141. PubMed ID: 27955628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease.
    Razavizade M; Jamali R; Arj A; Talari H
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):513-20. PubMed ID: 23060397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating miRNAs associated with nonalcoholic fatty liver disease.
    Atic AI; Thiele M; Munk A; Dalgaard LT
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C588-C602. PubMed ID: 36645666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNAs in non-alcoholic fatty liver disease.
    He Z; Hu C; Jia W
    Front Med; 2016 Dec; 10(4):389-396. PubMed ID: 27680976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
    Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
    J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Diagnostic Importance of Circulating MicroRNA for Non-Alcoholic Fatty Liver Disease (review of literature).].
    Gimadiev PP; Niiazov AR; Mukhin VE; Ogurtsov PP
    Klin Lab Diagn; 2019; 64(12):723-729. PubMed ID: 32040895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.
    Yang W; Huang H; Wang Y; Yu X; Yang Z
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):174-8. PubMed ID: 24025980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.
    Ye D; Zhang T; Lou G; Xu W; Dong F; Chen G; Liu Y
    Life Sci; 2018 Sep; 208():201-207. PubMed ID: 30030064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women.
    Oya J; Nakagami T; Sasaki S; Jimba S; Murakami K; Kasahara T; Wasada T; Sekiguchi H; Hasegawa M; Endo Y; Iwamoto Y
    Eur J Clin Nutr; 2010 Oct; 64(10):1179-85. PubMed ID: 20683463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
    Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E
    J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.